As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Edited by Sarah Tschudin-Sutter
We are proud to announce the publication of Impact of the environment on healthcare-associated infections . This is a collection of original works and reviews focusing on the role of the environment in promoting healthcare-associated infections and specific interventions targeting the hospital environment.
Health Policy and the Management of Antimicrobial Resistance in LMICs is now open for submissions.
This is a cross-journal series to highlight the challenges and developments within antimicrobial drug policies in low and middle income countries. Both reviews and original research articles are welcome.
Early-life gut microbiome modulation reduces the abundance of antibiotic-resistant bacteria
Antibiotic-resistant (AR) bacteria are a global threat, and can be acquired early on in life. Here, Casaburi et al. show how the infant gut microbiome can be modified, resulting in a significant reduction of AR genes (ARGs) and the potentially pathogenic bacteria that harbor them. Read More.
Here, we compile some handy tips for the community, from early-career researchers to clinicians on peer review. It may seem like a basic part of a reseacher’s role, but many basic and clinical researchers don’t get much training in the cornerstone of this life cycle of modern scientific literature.
Assessment by expert peers improves the quality of manuscripts and provides a level of control in scientific communication.
We've put together a short guide (Read more).
Antimicrobial Resistance and Infection Control is a global forum for all those working on the prevention, diagnosis and treatment of health-care-associated infections and antimicrobial resistance development in all health-care settings. The journal covers a broad spectrum of preeminent practices and best available data to the top interventional and translational research, and innovative developments in the field of infection control within the clinical and health-care context.
We are pleased to highlight that Antimicrobial Resistance & Infection Control recognises that scientifically sound, high quality manuscripts are often turned away from broad-scope "high-impact" journals based on the issue of "general interest." The journal will consider rapid publication of such manuscripts - if they are submitted together with the original peer reviewer reports, letter of rejection, and a rebuttal. Please also mention this in your cover letter.
Please note that additional peer review may be necessary and the final decision will be made by the Editor.
Antimicrobial Resistance and Infection Control is pleased to announce a new article collection entitled Society guidelines for best practices. Our aim is to offer the journal’s associated societies the opportunity to publish their guidelines in order to make them available for a broader audience.
Christina Vandenbroucke-Grauls, Editor-in-Chief
Dr Vandenbroucke-Grauls is professor of Medical Microbiology at the VU University (Amsterdam), The Netherlands. She holds an MD from the Catholic University of Leuven (Belgium) and a PhD from the Utrecht University (Utrecht, The Netherlands). She also holds a degree in Epidemiology (PhD equivalent) from the Dutch Society for Epidemiology. She is a Fellow of the Royal College of Physicians (FRCP).
Professor Vandenbroucke-Grauls is head of Department of Medical Microbiology & Infection Control at the VU University Medical Center. For over ten years she served as chair of the Dutch Working Party on Infection Control. She also served in several professional boards and national and international scientific committees. Her main work interest is in infection control and antimicrobial resistant pathogens (MRSA and ESBL- and carbapenemase-producing Enterobacteriaceae in particular).
Upcoming Conference - Liverpool, 22-24 September 2019
Upcoming Conference - Geneva, 10-13 September 2019
Speed
61 days to first decision for reviewed manuscripts only
43 days to first decision for all manuscripts
112 days from submission to acceptance
19 days from acceptance to publication
Citation Impact
3.224 - 2-year Impact Factor
3.680 - 5-year Impact Factor
1.498 - Source Normalized Impact per Paper (SNIP)
1.681 - SCImago Journal Rank (SJR)
Usage
767,422 downloads
2,556 Altmetric Mentions
